Is Time to First Recurrence of Atrial Fibrillation Correlated With Atrial Fibrillation Burden?

American Journal of Cardiology

Volumn 97, Issue 9, 2006, Pages 1343-1345

  Pérez, Francisco J ^a   Lung, Te Hsin ^b   Ellenbogen, Kenneth A ^a   Wood, Mark A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b Vitatron   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECURRENT DISEASE; STATISTICAL ANALYSIS; TIME;

AGED; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MODELS, CARDIOVASCULAR; PACEMAKER, ARTIFICIAL; RECURRENCE; REGISTRIES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 33646049059     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.11.050     Document Type: Article

References (13)

1. Wyse D.G. Selection of endpoints in atrial fibrillation studies. J Cardiovasc Electrophysiol 13 1 suppl (2002) S47-S52
2. Temple R. Are surrogate markers adequate to assess cardiovascular disease drugs?. JAMA 282 (1999) 790-795
3. Kaufman E.S., and Waldo A.L. The impact of asymptomatic atrial fibrillation. J Am Coll Cardiol 43 (2004) 53-54
4. Oral H., Veerareddy S., Good E., Hall B., Cheung P., Tamirisa K., Han J., Fortino J., Chugh A., Bogun F., Pelosi F.J., and Morady F. Prevalence of atrial fibrillation after successful radiofrequency catheter ablation. J Cardiovasc Electrophysiol 15 (2004) 920-924
5. Hindricks G., Piorkowski C., Tanner H., Kobza R., Gerds-Li J.H., Carbucicchio C., and Kottkamp H. Perception of atrial fibrillation before and after radiofrequency ablation. relevance of asymptomatic arrhythmia recurrence. Circulation 112 (2005) 307-313
6. Pritchett E.L., and Wilkinson W.E. Modeling recurrent arrhythmias. J Cardiovasc Electrophysiol 12 (2001) 131-133
7. Gillis A.M., and Rose M.S. Temporal patterns of paroxysmal atrial fibrillation following DDDR pacemaker implantation. Am J Cardiol 85 (2000) 1445-1450
8. Shehadeh L.A., Liebovitch L.S., and Wood M.A. Temporal patterns of atrial arrhythmia recurrences in patients with implantable defibrillators. implications for assessing antiarrhythmic therapies. J Cardiovasc Electrophysiol 13 (2002) 303-309
9. Euler D.E., and Friedman P.A. Atrial arrhythmia burden as an endpoint in clinical trials. is it the best surrogate? Lessons from a multicenter defibrillator trial. Cardiac Electrophysiol Rev 7 (2003) 355-358
10. Page R.L., Wilkinson W.E., Clair W.K., McCarthy E.A., and Pritchett E.L. Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 89 (1994) 224-227
11. Friedman P.A., Dijkman B., Warman E.N., Xia H.A., Mehra R., Stanton M.S., and Hammill S.C. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 104 (2001) 1023-1028
12. Israel C.W., Grönefeld G., Ehrlich J.R., Li Y., and Hohnloser S.H. Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device. implications for optimal patient care. J Am Coll Cardiol 43 (2004) 47-52
13. Gillis A.M., and Morck M. Atrial fibrillation after DDDR pacemaker implantation. J Cardiovasc Electrophysiol 13 (2002) 542-547